Cellectar Biosciences, Inc. (CLRB)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 1 signal for Cellectar Biosciences, Inc.. Most notable: 2026-07-10: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing director or officer change
  2. Material 8-K filing
    Filed 8-K disclosing director or officer change
  3. Material 8-K filing
    Filed 8-K disclosing material agreement
  4. Material 8-K filing
    Filed 8-K disclosing material agreement

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-05-07Longcor JarrodofficerP8,6802.88$24,998
2026-05-07CARUSO JAMES VdirectorP8,6802.88$24,998
2025-12-12NEIS JOHNdirectorS1983.7$733
2025-07-02CARUSO JAMES VdirectorP10,0004.99$49,900
2025-07-02Longcor JarrodofficerP10,0004.99$49,900
2025-07-02Kolean Chad JofficerP5,0004.99$24,950
2025-01-10Longcor JarrodofficerP30,0000.28$8,400

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings